Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Luxbright ABFRA:LUR 19 EV-to-EBIT is -0.22 as of Sep. 01, 2026. GuruFocus rates FRA:LUR with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 476 Medical Devices & Instruments companies, Luxbright AB ranks worse than 210083.82% on this metric.
The historical rank and industry rank for Luxbright AB's EV-to-EBIT or its related term are showing as below:
FRA:LUR'
s EV-to-EBIT Range Over the Past 10 Years
Min: -9.64 Med: -2.78 Max: 1.32
Current: -0.24
During the past 8 years, the highest EV-to-EBIT of Luxbright AB was 1.32. The lowest was -9.64. And the median was -2.78.
FRA:LUR's EV-to-EBIT is ranked worse than 100% of 476
companies
in the Medical Devices & Instruments industry
Industry Median: 19.145
vs FRA:LUR: -0.24
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Luxbright AB's Enterprise Value for the quarter that ended in Jun. 2026 was €1.40 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Luxbright AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luxbright AB EV-to-EBIT Related Terms
Luxbright AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Luxbright AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Luxbright AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Luxbright AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Luxbright AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Luxbright AB's EV-to-EBIT falls into.
Luxbright AB's current Enterprise Value is €0.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Luxbright AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luxbright AB (FRA:LUR) has a EV-to-EBIT of -0.22 as of Sep. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Luxbright AB and its competitors. According to the industry distribution chart, Luxbright AB ranks #999999 out of 476 companies in the Medical Devices & Instruments industry.
Is Luxbright AB's EV-to-EBIT too high?
Luxbright AB's current EV-to-EBIT is -0.22. Based on the distribution chart, Luxbright AB ranks #999999 out of 476 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Luxbright AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Luxbright AB's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Luxbright AB ranks #999999 out of 476 companies for EV-to-EBIT. This places Luxbright AB in the lower half of its industry. The industry median EV-to-EBIT is 19.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.15, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Luxbright AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Luxbright AB's current EV-to-EBIT is -0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Luxbright AB stock overvalued right now?
Luxbright AB (FRA:LUR) has a current EV-to-EBIT of -0.22. The current EV-to-EBIT is -0.22. Luxbright AB's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Luxbright AB (FRA:LUR), the current EV-to-EBIT is -0.22 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Luxbright AB is a technology company focusing on developing and commercializing a new generation of X-ray tubes. The company offers X-ray tubes, generators, and future X-ray systems to international system suppliers in order to improve and protect lives by enabling higher resolution X-ray images. The X-ray tubes are a powerful, stable, and cost-effective alternative to conventional X-ray tubes.
19GF Score
Get the complete analysis for FRA:LUR
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LUR has been successfully added to your 
